S.C. Ropharma S.A. (BVB: RPH)

S.C. Ropharma Ratios and Metrics

Market cap in millions RON. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 17, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	88	102	96	106	117	141
Market Cap Growth	4.17%	6.95%	-9.83%	-9.57%	-16.60%	-21.44%
Enterprise Value	236	225	217	236	257	231
Last Close Price	0.17	0.20	0.19	0.21	0.23	0.28
PE Ratio	2506.78	13.25	10.37	9.88	17.36	18.69
Forward PE	-	18.17	18.17	18.17	18.17	18.17
PS Ratio	0.07	0.09	0.10	0.12	0.15	0.18
PB Ratio	0.37	0.41	0.41	0.48	0.58	0.75
P/TBV Ratio	0.57	0.55	0.53	0.64	0.77	1.01
P/FCF Ratio	3.39	4.20	8.05	4.92	-	-
P/OCF Ratio	2.27	2.53	3.19	2.74	-	16.64
EV/Sales Ratio	0.20	0.20	0.22	0.27	0.32	0.30
EV/EBITDA Ratio	5.54	6.23	8.96	7.52	10.18	12.24
EV/EBIT Ratio	11.21	11.26	23.40	13.78	24.32	26.58
EV/FCF Ratio	9.10	9.27	18.24	10.95	-	-
Debt / Equity Ratio	0.66	0.65	0.64	0.62	0.72	0.77
Debt / EBITDA Ratio	3.89	3.52	4.49	3.40	4.39	5.30
Debt / FCF Ratio	6.40	6.74	12.48	6.35	-	-
Asset Turnover	1.44	1.42	1.39	1.35	1.22	1.35
Inventory Turnover	5.00	5.25	5.44	5.61	5.18	6.22
Quick Ratio	0.60	0.63	0.64	0.65	0.65	0.63
Current Ratio	1.01	1.01	1.01	1.01	1.00	0.96
Return on Equity (ROE)	2.00%	4.81%	3.31%	5.49%	2.37%	2.53%
Return on Assets (ROA)	1.60%	1.59%	0.80%	1.62%	1.00%	0.93%
Return on Capital (ROIC)	3.29%	3.14%	1.57%	3.04%	1.94%	1.86%
Earnings Yield	0.04%	7.55%	9.64%	10.12%	5.76%	5.35%
FCF Yield	29.52%	23.79%	12.42%	20.31%	-17.64%	-20.18%
Buyback Yield / Dilution	-0.90%	-	-	-0.30%	0.00%	0.18%
Total Shareholder Return	-0.90%	-	-	-0.30%	0.00%	0.18%

Source: S&P Capital IQ. Standard template. Financial Sources.